Thiazolidinediones: the Forgotten Diabetes Medications

PURPOSE OF REVIEW: Thiazolidinediones (TZDs) are the only pharmacologic agents that specifically treat insulin resistance. The beneficial effects of TZDs on the cardiovascular risk factors associated with insulin resistance have been well documented. TZD use has been limited because of concern about...

Descripción completa

Detalles Bibliográficos
Autor principal: Lebovitz, Harold E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881429/
https://www.ncbi.nlm.nih.gov/pubmed/31776781
http://dx.doi.org/10.1007/s11892-019-1270-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881429/
https://www.ncbi.nlm.nih.gov/pubmed/31776781
http://dx.doi.org/10.1007/s11892-019-1270-y

Ejemplares similares